From the Food and Drug Administration

JAMA. 2002 Feb 6;287(5):578.
No abstract available

MeSH terms

  • Administration, Cutaneous
  • Adult
  • Child
  • Contraceptive Agents, Female*
  • Dermatologic Agents / adverse effects*
  • Ethinyl Estradiol*
  • Female
  • Heart Septal Defects, Atrial / surgery*
  • Heart Septal Defects, Ventricular / surgery*
  • Humans
  • Isotretinoin / adverse effects*
  • Levonorgestrel* / analogs & derivatives
  • Male
  • Prostheses and Implants*
  • Risk Management
  • United States
  • United States Food and Drug Administration

Substances

  • Contraceptive Agents, Female
  • Dermatologic Agents
  • Ethinyl Estradiol
  • Levonorgestrel
  • Isotretinoin